Cti Biopharma reported $93K in Ordinary Share Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Applied Genetic Technologies AGTC:US $ 0.04M 0M
Baxter International BAX:US $ 683M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Cti Biopharma CTIC:US $ 0.09M 0.02M
Cytori Therapeutics CYTX:US $ 0.01M 0M
Eli Lilly And LLY:US $ 598.1M 1.6M
Mirati Therapeutics MRTX:US $ 0.05M 0M
Northwest Biotherapeutics NWBO:US 857K 15K
Novartis NOVN:VX SF 913M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Sunesis Pharmaceuticals SNSS:US $ 0M 0M
Teva Pharmaceutical Industries TEVA:US $ 57M 0M
YTE INCY:US $ 0.22M 0M